Estrogen Receptor–Positive, Progesterone Receptor–Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance

Estrogen Receptor–Positive, Progesterone Receptor–Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/dji249 ◽

2005 ◽

Vol 97 (17) ◽

pp. 1254-1261 ◽

Cited By ~ 327

Author(s):

Grazia Arpino ◽

Heidi Weiss ◽

Adrian V. Lee ◽

Rachel Schiff ◽

Sabino De Placido ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Tamoxifen Resistance ◽

Receptor Expression ◽

Estrogen Receptor Positive

Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-05-2128 ◽

2006 ◽

Vol 12 (3) ◽

pp. 1013s-1018s ◽

Cited By ~ 42

Author(s):

Hyun-Jung Kim ◽

Xiaojiang Cui ◽

Susan G. Hilsenbeck ◽

Adrian V. Lee

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Positive Breast Cancer

Abstract P2-06-03: Clinicopathologic characteristics and genomic essence analyses revealed estrogen receptor positive, progesterone receptor negative and human epidermal growth factor receptor 2 negative breast cancer to be more basal-like and endocrine resistant

10.1158/1538-7445.sabcs17-p2-06-03 ◽

2018 ◽

Author(s):

X Liu ◽

D Ma ◽

Y-Z Jiang ◽

Y-R Liu ◽

K-D Yu ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Clinicopathologic Characteristics ◽

Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Testing in Breast Cancer

Applied Immunohistochemistry & Molecular Morphology ◽

10.1097/pai.0000000000000525 ◽

2019 ◽

Vol 27 (1) ◽

pp. 1-7 ◽

Cited By ~ 1

Author(s):

Nosaibah Hariri ◽

Farnaz Hasteh ◽

Vighnesh Walavalkar ◽

Andres A. Roma ◽

Oluwole Fadare

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer

International Journal of General Medicine ◽

10.2147/ijgm.s314055 ◽

2021 ◽

Vol Volume 14 ◽

pp. 2777-2783

Author(s):

Gulijire Tailaiti ◽

Gulanbaier Maimaiti ◽

Youlituzi Aikeremu ◽

Batuer Tuerdi

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Invasive Breast Cancer ◽

Growth Factor Receptor ◽

X Ray ◽

Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells

Molecular Medicine Reports ◽

10.3892/mmr.2018.8580 ◽

2018 ◽

Cited By ~ 1

Author(s):

Seung Taek Lim ◽

Ye Won Jeon ◽

Hongki Gwak ◽

Se Young Kim ◽

Young Jin Suh

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Breast Cancer Cells ◽

Growth Factor Receptor ◽

Anticancer Effects ◽

Epidermal Growth ◽

Positive Breast Cancer

Correlation between microRNA-21, microRNA-206 and estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 in breast cancer

Clinical Biochemistry ◽

10.1016/j.clinbiochem.2019.07.002 ◽

2019 ◽

Vol 71 ◽

pp. 52-57 ◽

Cited By ~ 4

Author(s):

Yuanwen Chen ◽

Nian Wu ◽

Lei Liu ◽

Huaying Dong ◽

Chengyi Wu

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Abstract OT1-03-01: Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 in combination with alpelisib (BYL719) in estrogen receptor-positive (ER+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) with progression on endocrine therapy (ET)

10.1158/1538-7445.sabcs18-ot1-03-01 ◽

2019 ◽

Author(s):

G Curigliano ◽

S Cresta ◽

Y-S Yap ◽

D Juric ◽

FP Duhoux ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Advanced Breast Cancer ◽

Phase 1 ◽

Growth Factor Receptor ◽

Abstract PD7-07: Final analysis of phase 1 study of elacestrant (RAD1901), a novel selective estrogen receptor degrader (SERD), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer

10.1158/1538-7445.sabcs19-pd7-07 ◽

2020 ◽

Author(s):

Virginia Kaklamani ◽

Aditya Bardia ◽

Sharon Wilks ◽

Amy Weise ◽

Donald Richards ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Phase 1 ◽

Growth Factor Receptor ◽

Final Analysis ◽

Phase 1 Study ◽

Correlation of Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Progesterone Receptor (PR) Expression as Predicted by Core Biopsy with the Immunohistochemical Results of Surgical Breast Cancer Specimens

Breast Care ◽

10.1159/000101429 ◽

2007 ◽

Vol 2 (2) ◽

pp. 94-98 ◽

Cited By ~ 2

Author(s):

Julian Erggelet ◽

Regina Grosse ◽

Hans-Jürgen Holzhausen ◽

Steffen Hauptmannb,Christoph Thomssen

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Core Biopsy ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽